• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Bausch + Lomb Corporation Common Shares (NY:BLCO)

    18.40 -0.20 (-1.08%)
    Streaming Delayed Price Updated: 3:22 PM EST, Feb 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 285,500
    Open 18.58
    Bid (Size) 18.39 (900)
    Ask (Size) 18.41 (400)
    Prev. Close 18.60
    Today's Range 17.98 - 18.61
    52wk Range 10.45 - 18.91
    Shares Outstanding 353,800,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    5 Revealing Analyst Questions From Bausch + Lomb’s Q4 Earnings Call
    Bausch + Lomb’s fourth quarter showed strong revenue growth but fell short on non-GAAP profit expectations, prompting a modestly negative market reaction. Management attributed the performance to... 
    Via StockStory
    Topics Earnings
    News headline image
    Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY®
    From Bausch + Lomb Corporation
    Via Business Wire

    Performance

    YTD
    +11.0%
    +11.0%
    1 Month
    +9.1%
    +9.1%
    3 Month
    +13.6%
    +13.6%
    6 Month
    +26.5%
    +26.5%
    1 Year
    +15.2%
    +15.2%

    More News

    Read More
    News headline image
    3 Small-Cap Stocks We Steer Clear Of
    Via StockStory
    Bausch + Lomb Corp (NYSE:BLCO) Reports Mixed Q4 2025 Results: Revenue Beat, EPS Miss ↗
    Via Chartmill
    News headline image
    BLCO Q4 2025 Deep Dive: Dry Eye and Product Innovation Propel Growth, Margin Expansion in Focus
    Via StockStory
    News headline image
    Bausch + Lomb’s (NYSE:BLCO) Q4 CY2025: Beats On Revenue
    Via StockStory
    News headline image
    Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb (BLCO) Q4 Earnings: What To Expect
    Via StockStory
    Topics World Trade
    News headline image
    3 Reasons to Sell BLCO and 1 Stock to Buy Instead
    Via StockStory
    Topics Bankruptcy Stocks
    News headline image
    1 Healthcare Stock to Research Further and 2 Facing Headwinds
    Via StockStory
    Topics Stocks
    News headline image
    3 Stocks Under $50 That Fall Short
    Via StockStory
    News headline image
    3 Cash-Burning Stocks We’re Skeptical Of
    Via StockStory
    Topics Bankruptcy
    News headline image
    Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Completes Refinancing of Outstanding Term B Loans
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    1 Profitable Stock to Keep an Eye On and 2 We Question
    Via StockStory
    News headline image
    Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year ↗
    Via The Motley Fool
    News headline image
    Bausch + Lomb Announces Two Board of Directors Appointments
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Why Bausch + Lomb (BLCO) Stock Is Trading Up Today
    Via StockStory
    Topics Artificial Intelligence Initial Public Offering
    News headline image
    3 Healthcare Stocks We Think Twice About
    Via StockStory
    Topics Stocks
    News headline image
    BLCO Stock Still 16% Below IPO — Is Silver Point’s $38.7 Million Bet a Turning Point? ↗
    Via The Motley Fool
    Topics Initial Public Offering Regulatory Compliance
    News headline image
    Why Bausch + Lomb (BLCO) Stock Is Up Today
    Via StockStory
    Topics Economy Initial Public Offering
    News headline image
    3 Small-Cap Stocks with Warning Signs
    Via StockStory

    Frequently Asked Questions

    Is Bausch + Lomb Corporation Common Shares publicly traded?
    Yes, Bausch + Lomb Corporation Common Shares is publicly traded.
    What exchange does Bausch + Lomb Corporation Common Shares trade on?
    Bausch + Lomb Corporation Common Shares trades on the New York Stock Exchange
    What is the ticker symbol for Bausch + Lomb Corporation Common Shares?
    The ticker symbol for Bausch + Lomb Corporation Common Shares is BLCO on the New York Stock Exchange
    What is the current price of Bausch + Lomb Corporation Common Shares?
    The current price of Bausch + Lomb Corporation Common Shares is 18.40
    When was Bausch + Lomb Corporation Common Shares last traded?
    The last trade of Bausch + Lomb Corporation Common Shares was at 02/26/26 03:22 PM ET
    What is the market capitalization of Bausch + Lomb Corporation Common Shares?
    The market capitalization of Bausch + Lomb Corporation Common Shares is 6.51B
    How many shares of Bausch + Lomb Corporation Common Shares are outstanding?
    Bausch + Lomb Corporation Common Shares has 7B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.